Vitasora HealthASX:VHL EBIT per Share is A$-0.01 as of Dec. 2025. The stock has 6 warning signs investors should review. Among 529 Healthcare Providers & Services companies, Vitasora Health ranks worse than 57.84% on this metric.
Vitasora Health's EBIT per Share for the
six
months ended in Dec. 2025 was A$-0.00.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was A$-0.01.
During the past 3 years, the average EBIT per Share Growth Rate was 7.20% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 16.40% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 5.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Vitasora Health's EBIT per Share or its related term are showing as below:
ASX:VHL'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -86.2 Med: 23.1 Max: 85.8
Current: 7.2
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Vitasora Health was 85.80% per year. The lowest was -86.20% per year. And the median was 23.10% per year.
ASX:VHL's 3-Year EBIT Growth Rate is ranked worse than 57.84% of 529
companies
in the Healthcare Providers & Services industry
Industry Median: 12.1
vs ASX:VHL: 7.20
Vitasora Health's EBIT for the
six
months ended in Dec. 2025 was A$-5.60 Mil.
Vitasora Health (ASX:VHL) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Vitasora Health EBIT per Share Related Terms
Vitasora Health EBIT per Share Historical Data
* Premium members only.
The historical data trend for Vitasora Health's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.01
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vitasora Health (ASX:VHL) has a EBIT per Share of A$-0.01 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Vitasora Health and its competitors. According to the industry distribution chart, Vitasora Health ranks #306 out of 529 companies in the Healthcare Providers & Services industry, placing it in the top 57.8%.
Is Vitasora Health's EBIT per Share too high?
Vitasora Health's current EBIT per Share is A$-0.01. Based on the distribution chart, Vitasora Health ranks #306 out of 529 companies in the Healthcare Providers & Services industry, which is below the industry midpoint.
How does Vitasora Health's EBIT per Share compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Vitasora Health ranks #306 out of 529 companies for EBIT per Share. This places Vitasora Health in the lower half of its industry. The industry median EBIT per Share is 12.10. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 12.10, based on 529 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Vitasora Health and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 12.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vitasora Health's current EBIT per Share is A$-0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitasora Health stock overvalued right now?
Vitasora Health (ASX:VHL) has a current EBIT per Share of A$-0.01. The current EBIT per Share is A$-0.01. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Vitasora Health (ASX:VHL), the current EBIT per Share is A$-0.01 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vitasora Health Ltd is engaged in healthcare technology and services, providing critical patient health tracking services to clinicians and healthcare teams. Through data-driven programs, clinical technology, and support tools, it enables healthcare professionals to extend the capacity of care beyond the clinic. The company operates in Australia and the USA, with the majority of its revenue coming from the USA. The United States reportable segment, through the acquisition of Access Telehealth and Orb Health, provides reportable segment activities such as a broader value proposition and solutions for managing the majority chronic disease states, including Cardiovascular, Diabetes, Chronic Obstructive Pulmonary Disease (COPD), and Obesity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:VHL has been successfully added to your 